245 related articles for article (PubMed ID: 24475704)
1. [Design, synthesis and evaluation of bis-nicotine derivatives as inhibitors of cholinesterases and beta-amyloid aggregation].
Luo W; Zhao YM; Tian RG; Su YB; Hong C
Yao Xue Xue Bao; 2013 Nov; 48(11):1671-6. PubMed ID: 24475704
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and evaluation of novel 4-dimethylamine flavonoid derivatives as potential multi-functional anti-Alzheimer agents.
Luo W; Su YB; Hong C; Tian RG; Su LP; Wang YQ; Li Y; Yue JJ; Wang CJ
Bioorg Med Chem; 2013 Dec; 21(23):7275-82. PubMed ID: 24148835
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and evaluation of novel tacrine-multialkoxybenzene hybrids as dual inhibitors for cholinesterases and amyloid beta aggregation.
Luo W; Li YP; He Y; Huang SL; Tan JH; Ou TM; Li D; Gu LQ; Huang ZS
Bioorg Med Chem; 2011 Jan; 19(2):763-70. PubMed ID: 21211982
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of heterobivalent tacrine derivatives as potential multi-functional anti-Alzheimer agents.
Luo W; Li YP; He Y; Huang SL; Li D; Gu LQ; Huang ZS
Eur J Med Chem; 2011 Jun; 46(6):2609-16. PubMed ID: 21497959
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase.
Ghafary S; Ghobadian R; Mahdavi M; Nadri H; Moradi A; Akbarzadeh T; Najafi Z; Sharifzadeh M; Edraki N; Moghadam FH; Amini M
Daru; 2020 Dec; 28(2):463-477. PubMed ID: 32372339
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase.
Kilic B; Gulcan HO; Aksakal F; Ercetin T; Oruklu N; Umit Bagriacik E; Dogruer DS
Bioorg Chem; 2018 Sep; 79():235-249. PubMed ID: 29775949
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of 7,8-dehydrorutaecarpine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
He Y; Yao PF; Chen SB; Huang ZH; Huang SL; Tan JH; Li D; Gu LQ; Huang ZS
Eur J Med Chem; 2013 May; 63():299-312. PubMed ID: 23501115
[TBL] [Abstract][Full Text] [Related]
8. [Design, synthesis and cholinesterase inhibitory activity of quinoline-polyamine conjugates].
Luo W; Huang K; Zhang Z; Hong C; Wang CJ
Yao Xue Xue Bao; 2013 Feb; 48(2):269-75. PubMed ID: 23672025
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and evaluation of novel 7-aminoalkyl-substituted flavonoid derivatives with improved cholinesterase inhibitory activities.
Luo W; Chen Y; Wang T; Hong C; Chang LP; Chang CC; Yang YC; Xie SQ; Wang CJ
Bioorg Med Chem; 2016 Feb; 24(4):672-80. PubMed ID: 26752094
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of benzofuran appended benzothiazepine derivatives as inhibitors of butyrylcholinesterase and antimicrobial agents.
Mostofi M; Mohammadi Ziarani G; Lashgari N
Bioorg Med Chem; 2018 Jul; 26(12):3076-3095. PubMed ID: 29866481
[TBL] [Abstract][Full Text] [Related]
11. New potent human acetylcholinesterase inhibitors in the tetracyclic triterpene series with inhibitory potency on amyloid β aggregation.
Rouleau J; Iorga BI; Guillou C
Eur J Med Chem; 2011 Jun; 46(6):2193-205. PubMed ID: 21435752
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and evaluation of 4-dimethylamine flavonoid derivatives as potential multifunctional anti-Alzheimer agents.
Luo W; Wang T; Hong C; Yang YC; Chen Y; Cen J; Xie SQ; Wang CJ
Eur J Med Chem; 2016 Oct; 122():17-26. PubMed ID: 27343850
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, biological evaluation, and docking study of novel dual-acting thiazole-pyridiniums inhibiting acetylcholinesterase and β-amyloid aggregation for Alzheimer's disease.
Ghotbi G; Mahdavi M; Najafi Z; Moghadam FH; Hamzeh-Mivehroud M; Davaran S; Dastmalchi S
Bioorg Chem; 2020 Oct; 103():104186. PubMed ID: 32890993
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional novel Diallyl disulfide (DADS) derivatives with β-amyloid-reducing, cholinergic, antioxidant and metal chelating properties for the treatment of Alzheimer's disease.
Manral A; Saini V; Meena P; Tiwari M
Bioorg Med Chem; 2015 Oct; 23(19):6389-403. PubMed ID: 26337018
[TBL] [Abstract][Full Text] [Related]
16. Novel tetrahydroacridine derivatives with iodobenzoic acid moiety as multifunctional acetylcholinesterase inhibitors.
Skibiński R; Czarnecka K; Girek M; Bilichowski I; Chufarova N; Mikiciuk-Olasik E; Szymański P
Chem Biol Drug Des; 2018 Feb; 91(2):505-518. PubMed ID: 28944565
[TBL] [Abstract][Full Text] [Related]
17. [Design, synthesis and evaluation of tacrine-methoxybenzene hybrids as cholinesterases inhibitors].
Luo W; Zhao YM; Zhang Z; Su YB; Wang CJ
Yao Xue Xue Bao; 2012 Jul; 47(7):916-21. PubMed ID: 22993857
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of benzo[e][1,2,4]triazin-7(1H)-one and [1,2,4]-triazino[5,6,1-jk]carbazol-6-one derivatives as dual inhibitors of beta-amyloid aggregation and acetyl/butyryl cholinesterase.
Catto M; Berezin AA; Lo Re D; Loizou G; Demetriades M; De Stradis A; Campagna F; Koutentis PA; Carotti A
Eur J Med Chem; 2012 Dec; 58():84-97. PubMed ID: 23108363
[TBL] [Abstract][Full Text] [Related]
19. Novel oxoisoaporphine-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
Tang H; Zhao HT; Zhong SM; Wang ZY; Chen ZF; Liang H
Bioorg Med Chem Lett; 2012 Mar; 22(6):2257-61. PubMed ID: 22341944
[TBL] [Abstract][Full Text] [Related]
20. Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Brunhofer G; Fallarero A; Karlsson D; Batista-Gonzalez A; Shinde P; Gopi Mohan C; Vuorela P
Bioorg Med Chem; 2012 Nov; 20(22):6669-79. PubMed ID: 23062825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
